Log In
Print
BCIQ
Print
Print this Print this
 

Adagen, adenosine deaminase (PEG-adenosine deaminase)

  Manage Alerts
Collapse Summary General Information
Company Sigma-Tau Group
DescriptionPegylated adenosine deaminase
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationImmunodeficiency
Indication DetailsTreat severe combined immunodeficiency disease (SCID)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today